Revenue: The sum of all revenue fields included for a company's operating activities.
TG Therapeutics, Inc. (TGTX) had Revenue of $192.57M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
$192.57M |
$23.04M |
|
$38.14M |
|
$154.43M |
|
$142.08M |
|
$50.49M |
|
$-5.40M |
|
$45.09M |
|
$45.09M |
|
$23.04M |
|
$23.04M |
|
$23.04M |
|
$23.04M |
|
$50.49M |
|
$50.48M |
|
144.32M |
|
161.41M |
|
$0.19 |
|
$0.14 |
|
| Balance Sheet Financials | |
$630.76M |
|
-- |
|
$432.49M |
|
$1.06B |
|
$153.76M |
|
$245.65M |
|
$261.47M |
|
$415.23M |
|
$648.02M |
|
$648.02M |
|
$648.02M |
|
155.31M |
|
| Cash Flow Statement Financials | |
$-24.77M |
|
$13.80M |
|
$-89.73M |
|
$181.19M |
|
$80.49M |
|
$-100.70M |
|
$64.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.10 |
|
-- |
|
-- |
|
0.27 |
|
0.38 |
|
80.19% |
|
26.22% |
|
26.22% |
|
-- |
|
23.42% |
|
11.96% |
|
$-24.99M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
0.30 |
|
0.63 |
|
142.84 |
|
3.56% |
|
3.56% |
|
2.17% |
|
2.58% |
|
$4.17 |
|
$-0.15 |
|
$-0.15 |
|